Klor-con and Urocit-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Urocit-k (potassium citrate). Common drug interactions include basal cell carcinoma among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Urocit-k. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Urocit-k?

Urocit-k has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 708 Urocit-k users. Check the latest studies of Urocit-k.



On Jul, 19, 2026

15 people who take Klor-con and Urocit-k together, and have interactions are studied.

Klor-con and Urocit-k drug interactions.

What are the common drug interactions of Klor-Con and Urocit-K, by gender? *:

female:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  3. Bullous lung disease
  4. Cardiomegaly (increased size of heart than normal)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  7. Decreased appetite
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Diarrhoea
  10. Duodenal polyp (duodenal epithelial tumours)

male:

  1. Anaemia (lack of blood)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Agitation (state of anxiety or nervous excitement)
  5. Anaemia megaloblastic (disorder of abnormally large red blood cells)
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  8. Angioplasty
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Arrhythmia (irregular heartbeat)

What are the common drug interactions of Klor-Con and Urocit-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Fatigue (feeling of tiredness)
  2. Upper limb fracture
  3. Weight decreased
  4. Actinic keratosis (skin disease due to sun exposure)
  5. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  6. Anaemia macrocytic (a macrocytic class of anaemia)
  7. Anaemia of malignant disease
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. Arteriosclerosis (thickening and hardening of arteries)

50-59:

  1. Bullous lung disease
  2. Cardiomegaly (increased size of heart than normal)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  5. Decreased appetite
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Diarrhoea
  8. Duodenal polyp (duodenal epithelial tumours)
  9. Erythema (redness of the skin)
  10. Exposed bone in jaw

60+:

  1. Anaemia (lack of blood)
  2. Appendicitis (inflammation of the appendix)
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Agitation (state of anxiety or nervous excitement)
  5. Anaemia megaloblastic (disorder of abnormally large red blood cells)
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  8. Angioplasty
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Arrhythmia (irregular heartbeat)

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 40.00%
  2. Osteoporosis (bones weak and more likely to break): 6 people, 40.00%
  3. High Blood Cholesterol: 4 people, 26.67%
  4. Bone Loss: 4 people, 26.67%
  5. Insomnia (sleeplessness): 3 people, 20.00%
  6. Asthma: 3 people, 20.00%
  7. Headache (pain in head): 3 people, 20.00%
  8. Depression: 3 people, 20.00%
  9. Hypersensitivity: 3 people, 20.00%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Urocit-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Klor-con and Urocit-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Urocit-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Urocit-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and potassium citrate (the active ingredients of Klor-con and Urocit-k, respectively), and Klor-con and Urocit-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: